Chandan Healthcare (NSE:CHANDAN) Marketable Securities: ₹0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CHANDAN Chandan Healthcare Ltd NSE:CHANDAN
18 GF Score
Price ₹226.25
! 4 Warning Signs
View Full Analysis

What is Chandan Healthcare Marketable Securities?

Chandan Healthcare NSE:CHANDAN +2.77% 18 Marketable Securities is ₹0 Mil as of Dec. 2025. GuruFocus rates NSE:CHANDAN with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Chandan Healthcare's Marketable Securities for the quarter that ended in Dec. 2025 was ₹0 Mil.

Chandan Healthcare's annual Marketable Securities declined from Mar. 2023 (₹29 Mil) to Mar. 2024 (₹13 Mil) but then increased from Mar. 2024 (₹13 Mil) to Mar. 2025 (₹158 Mil).

Chandan Healthcare  (NSE:CHANDAN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Chandan Healthcare Marketable Securities Related Terms

Chandan Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Chandan Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandan Healthcare Marketable Securities Chart

Chandan Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Marketable Securities
0.00 28.62 13.47 158.37

Chandan Healthcare Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Dec25
Marketable Securities Get a 7-Day Free Trial 13.47 0.00 158.37 0.00 0.00
NSE:CHANDAN
18GF Score
Chandan Healthcare Ltd NSE:CHANDAN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandan Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Chandan Healthcare (NSE:CHANDAN) has a Marketable Securities of ₹0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Chandan Healthcare and its competitors.
Is Chandan Healthcare's Marketable Securities too high?
Chandan Healthcare's current Marketable Securities is ₹0 Mil. Overall, Chandan Healthcare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Marketable Securities compare to TMO and DHR?
Chandan Healthcare's Marketable Securities of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Chandan Healthcare and its competitors. Chandan Healthcare's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Marketable Securities of ₹0 Mil. The current Marketable Securities is ₹0 Mil. Chandan Healthcare's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Marketable Securities is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chandan Healthcare Business Description

Address Kursi Road, Biotech Park, Sector G, Jankipuram, Lucknow, UP, IND, 226021
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
18GF Score

Get the complete analysis for NSE:CHANDAN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹226.25
Price